Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
13.00
+0.31 (2.44%)
Aug 6, 2026, 11:41 AM EDT - Market open
Benitec Biopharma Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Benitec Biopharma stock has a consensus rating of "Strong Buy" and an average price target of $24.17. The average 1-year stock price forecast is 85.92% higher than the current stock price, while the lowest is $16 (+23.08%) and the highest is $32 (+146.15%).
Price Target: $24.17 (+85.92%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Benitec Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Initiates $16 | Buy | Initiates | $16 | +23.08% | Jul 28, 2026 |
| Guggenheim | Guggenheim | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $32 | Buy | Reiterates | $32 | +146.15% | May 26, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $18 | Buy | Reiterates | $18 | +38.46% | May 15, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
18.22M
EPS This Year
-10.37
EPS Next Year
6.29
from -10.37
EPS and Forward PE are based on non-GAAP adjusted numbers.